Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 10/2017

01-10-2017 | Original Article

Analysis of the incidence and risk factors of male urinary tract infection following urodynamic study

Authors: Z. Huang, H. Xiao, H. Li, W. Yan, Z. Ji

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 10/2017

Login to get access

Abstract

The purpose of this study was to investigate the incidence and risk factors of male urinary tract infection (UTI) after urodynamic study (UDS). A total of 854 consecutive male patients, who underwent UDS at Peking Union Medical College Hospital from January 2010 to March 2016, were recruited in this study. Two to four weeks before the examination, urinalysis with bacterial culture was performed. Patients with negative results were selected for UDS. Immediately before the examination, urinalysis was repeated to rule out any preoperative UTI. Between 48 and 72 h after the exam, urine culture was performed again to determine the incidence of UTI. The incidence of UTI and patients’ baseline characteristics, including age, medical history, urodynamic parameters, current diagnosis and pathogen type, were analyzed. Among the 854 patients undergoing UDS, urinary infection was found in 84 cases after the examination, the incidence was 9.83%. Comorbidity with diabetes, post void residual (PVR), volume of prostate (Vp), and two urodynamic parameters, maximal flow rate (Qmax) and average flow rate (Qav) were found to be the independent risk factors for UTI after UDS. The most common pathogens were Escherichia coli (54.76%) and Enterococcus faecalis (19.05%). The incidence of UTI after UDS in male patients was 9.83%. Patients who suffered from comorbidity of diabetes, high PVR, high Vp, low Qmax or Qav may need to be treated with prophylactic antibiotics to prevent postoperative UTI.
Literature
2.
go back to reference Wang J, Zhang Y, Song B et al (2012) Current status and prospect of urinary control in urology and female urology in China. Chin J Urol 33(9):647–650 Wang J, Zhang Y, Song B et al (2012) Current status and prospect of urinary control in urology and female urology in China. Chin J Urol 33(9):647–650
3.
go back to reference Liu N, He F, Man L et al (2012) The difference in urodynamic examination between DHIC patients and patients with DHIC combined with BOO and the effect of anticholinergic drug treatment. Chin Med J 92(26):1824–1827 Liu N, He F, Man L et al (2012) The difference in urodynamic examination between DHIC patients and patients with DHIC combined with BOO and the effect of anticholinergic drug treatment. Chin Med J 92(26):1824–1827
4.
go back to reference Yip SK, Fung K, Pang MW et al (2004) A study of female urinary tract infection caused by urodynamic investigation. Am J Obstet Gynecol 190(2):123–124 Yip SK, Fung K, Pang MW et al (2004) A study of female urinary tract infection caused by urodynamic investigation. Am J Obstet Gynecol 190(2):123–124
5.
go back to reference Tsai SW, Kung FT, Chuang FC et al (2013) Evaluation of the relationship between urodynamic examination and urinary tract infection based on urinalysis results. Taiwan J Obstet Gynecol 52(7):493–497CrossRefPubMed Tsai SW, Kung FT, Chuang FC et al (2013) Evaluation of the relationship between urodynamic examination and urinary tract infection based on urinalysis results. Taiwan J Obstet Gynecol 52(7):493–497CrossRefPubMed
6.
go back to reference Wen J, Zhu W (2013) Clinical progress of dynamic urodynamic examination. Chin J Urol 34(5):317–320 Wen J, Zhu W (2013) Clinical progress of dynamic urodynamic examination. Chin J Urol 34(5):317–320
7.
go back to reference Hwang SI, Lee BS, Han ZA, Lee HJ, Han SH, Kim MO (2016) Factors related to the occurrence of urinary tract infection following a urodynamic study in patients with spinal cord injury. Ann Rehabil Med 40(4):718–724CrossRefPubMedPubMedCentral Hwang SI, Lee BS, Han ZA, Lee HJ, Han SH, Kim MO (2016) Factors related to the occurrence of urinary tract infection following a urodynamic study in patients with spinal cord injury. Ann Rehabil Med 40(4):718–724CrossRefPubMedPubMedCentral
8.
go back to reference Nóbrega MM, Auge AP, de Toledo LG, da Silva CS, Frade AB, Salles MJ (2015) Bacteriuria and urinary tract infection after female urodynamic studies: risk factors and microbiological analysis. Am J Infect Control 43(10):1035–1039CrossRefPubMed Nóbrega MM, Auge AP, de Toledo LG, da Silva CS, Frade AB, Salles MJ (2015) Bacteriuria and urinary tract infection after female urodynamic studies: risk factors and microbiological analysis. Am J Infect Control 43(10):1035–1039CrossRefPubMed
9.
go back to reference Heckler AM, Sung J, Watters S, Martinez Acevedo A, Conlin M, Skoog S (2014) The long-term incidence of urinary tract infection after endoscopic management of vesicoureteral reflux. Urology 83(6):1383–1387CrossRefPubMed Heckler AM, Sung J, Watters S, Martinez Acevedo A, Conlin M, Skoog S (2014) The long-term incidence of urinary tract infection after endoscopic management of vesicoureteral reflux. Urology 83(6):1383–1387CrossRefPubMed
10.
go back to reference Christian R (2014) Do prophylactic antibiotics reduce UTI risk after urodynamic studies? Am J Nurs 114(2):20CrossRefPubMed Christian R (2014) Do prophylactic antibiotics reduce UTI risk after urodynamic studies? Am J Nurs 114(2):20CrossRefPubMed
11.
go back to reference Weglinski L, Rouzaud C, Even A, Bouchand F, Davido B, Duran C, Salomon J, Perronne C, Denys P, Chartier-Kastler E, Dinh A (2016) Prospective evaluation of antibiotic treatment for urological procedure in patients presenting with neurogenic bladder. Med Mal Infect 46(6):300–307CrossRefPubMed Weglinski L, Rouzaud C, Even A, Bouchand F, Davido B, Duran C, Salomon J, Perronne C, Denys P, Chartier-Kastler E, Dinh A (2016) Prospective evaluation of antibiotic treatment for urological procedure in patients presenting with neurogenic bladder. Med Mal Infect 46(6):300–307CrossRefPubMed
12.
go back to reference Mirone V, Franco M (2014) Clinical aspects of antimicrobial prophylaxis for invasive urological procedures. J Chemother 26(Suppl 1):S1–S13CrossRefPubMed Mirone V, Franco M (2014) Clinical aspects of antimicrobial prophylaxis for invasive urological procedures. J Chemother 26(Suppl 1):S1–S13CrossRefPubMed
13.
go back to reference Rahardjo HE, Tirtayasa PM, Afriansyah A, Parikesit D, Akbar MI (2016) The effectiveness of a three day course antibiotic post-urodynamic study in preventing lower urinary tract infection. Acta Med Indones 48(2):84–90PubMed Rahardjo HE, Tirtayasa PM, Afriansyah A, Parikesit D, Akbar MI (2016) The effectiveness of a three day course antibiotic post-urodynamic study in preventing lower urinary tract infection. Acta Med Indones 48(2):84–90PubMed
14.
go back to reference Tsai SW, Kung FT, Chuang FC, Ou YC, Wu CJ, Huang KH (2013) Evaluation of the relationship between urodynamic examination and urinary tract infection based on urinalysis results. Taiwan J Obstet Gynecol 52(4):493–497CrossRefPubMed Tsai SW, Kung FT, Chuang FC, Ou YC, Wu CJ, Huang KH (2013) Evaluation of the relationship between urodynamic examination and urinary tract infection based on urinalysis results. Taiwan J Obstet Gynecol 52(4):493–497CrossRefPubMed
15.
go back to reference Yokoyama T, Nozaki K, Nose H, Inoue M, Nishiyama Y, Kumoh H (2005) Tolerability and morbidity of urodynamic testing: a questionnaire-based study. Urology 66(1):74–76CrossRefPubMed Yokoyama T, Nozaki K, Nose H, Inoue M, Nishiyama Y, Kumoh H (2005) Tolerability and morbidity of urodynamic testing: a questionnaire-based study. Urology 66(1):74–76CrossRefPubMed
16.
go back to reference Dmochowski RR (2005) Bladder outlet obstruction: etiology and evaluation. Rev Urol 7(1):3–13 Dmochowski RR (2005) Bladder outlet obstruction: etiology and evaluation. Rev Urol 7(1):3–13
17.
go back to reference Guan Y, Pang Z, Wei J et al (2008) Correlation of prostate volume measured with transabdominal ultrasonography with parameters of UDS. Zhongguo Yi Xue Za Zhi 88(14):977–979 Guan Y, Pang Z, Wei J et al (2008) Correlation of prostate volume measured with transabdominal ultrasonography with parameters of UDS. Zhongguo Yi Xue Za Zhi 88(14):977–979
18.
go back to reference Aragón IM, Herrera-Imbroda B, Queipo-Ortuño MI, Castillo E, Sequeira-García Del Moral J, Gómez-Millán J, Yucel G, Lara MF. The Urinary Tract Microbiome in Health and Disease. Eur Urol Focus 2016 (in press). doi:10.1016/j.euf.2016.11.001 Aragón IM, Herrera-Imbroda B, Queipo-Ortuño MI, Castillo E, Sequeira-García Del Moral J, Gómez-Millán J, Yucel G, Lara MF. The Urinary Tract Microbiome in Health and Disease. Eur Urol Focus 2016 (in press). doi:10.​1016/​j.​euf.​2016.​11.​001
Metadata
Title
Analysis of the incidence and risk factors of male urinary tract infection following urodynamic study
Authors
Z. Huang
H. Xiao
H. Li
W. Yan
Z. Ji
Publication date
01-10-2017
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 10/2017
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-017-3007-7

Other articles of this Issue 10/2017

European Journal of Clinical Microbiology & Infectious Diseases 10/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.